GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder
Ziv Gan-Or,Anat Mirelman,Ronald B Postuma,Isabelle Arnulf,Anat Bar-Shira,Yves Dauvilliers,Alex Desautels,Jean-François Gagnon,Claire S Leblond,Birgit Frauscher,Roy N Alcalay,Rachel Saunders-Pullman,Susan B Bressman,Karen Marder,Christelle Monaca,Birgit Högl,Avi Orr-Urtreger,Patrick A Dion,Jacques Y Montplaisir,Nir Giladi,Guy A Rouleau,Ziv Gan‐Or,Ronald B. Postuma,Anat Bar‐Shira,Jean‐François Gagnon,Claire S. Leblond,Roy N. Alcalay,Rachel Saunders‐Pullman,Susan B. Bressman,Avi Orr‐Urtreger,Patrick A. Dion,Jacques Y. Montplaisir,Guy A. Rouleau
DOI: https://doi.org/10.1002/acn3.228
IF: 5.43
2015-07-31
Annals of Clinical and Translational Neurology
Abstract:Rapid eye movement sleep behavior disorder and GBA mutations are both associated with Parkinson's disease. The GBA gene was sequenced in idiopathic rapid eye movement sleep behavior disorder patients (n = 265), and compared to controls (n = 2240). Rapid eye movement sleep behavior disorder questionnaire was performed in an independent Parkinson's disease cohort (n = 120). GBA mutations carriers had an OR of 6.24 (10.2% in patients vs. 1.8% in controls, P < 0.0001) for rapid eye movement sleep behavior disorder, and among Parkinson's disease patients, the OR for mutation carriers to have probable rapid eye movement sleep behavior disorder was 3.13 (P = 0.039). These results demonstrate that rapid eye movement sleep behavior disorder is associated with GBA mutations, and that combining genetic and prodromal data may assist in identifying individuals susceptible to Parkinson's disease.
neurosciences,clinical neurology